205 related articles for article (PubMed ID: 18538833)
1. Is there any possibility of fertility-sparing surgery in patients with clear-cell carcinoma of the ovary?
Kajiyama H; Shibata K; Suzuki S; Ino K; Yamamoto E; Mizuno K; Sakakibara K; Matsuzawa K; Takeda A; Kinoshita Y; Kawai M; Nagasaka T; Nawa A; Kikkawa F
Gynecol Oncol; 2008 Dec; 111(3):523-6. PubMed ID: 18538833
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.
Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2008 Sep; 110(3):345-53. PubMed ID: 18586310
[TBL] [Abstract][Full Text] [Related]
3. Fertility-sparing surgery in young women with invasive epithelial ovarian cancer.
Kajiyama H; Shibata K; Suzuki S; Ino K; Nawa A; Kawai M; Nagasaka T; Kikkawa F
Eur J Surg Oncol; 2010 Apr; 36(4):404-8. PubMed ID: 20116965
[TBL] [Abstract][Full Text] [Related]
4. Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.
Winter WE; Maxwell GL; Tian C; Sundborg MJ; Rose GS; Rose PG; Rubin SC; Muggia F; McGuire WP;
J Clin Oncol; 2008 Jan; 26(1):83-9. PubMed ID: 18025437
[TBL] [Abstract][Full Text] [Related]
5. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
[TBL] [Abstract][Full Text] [Related]
6. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9).
Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D
Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258
[TBL] [Abstract][Full Text] [Related]
7. Survival impact of capsule rupture in stage I clear cell carcinoma of the ovary in comparison with other histological types.
Higashi M; Kajiyama H; Shibata K; Mizuno M; Mizuno K; Hosono S; Kawai M; Nakanishi T; Nagasaka T; Kikkawa F
Gynecol Oncol; 2011 Dec; 123(3):474-8. PubMed ID: 21955484
[TBL] [Abstract][Full Text] [Related]
8. Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
Park JY; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2009 Apr; 113(1):75-82. PubMed ID: 19171373
[TBL] [Abstract][Full Text] [Related]
9. Conservative treatment in epithelial ovarian cancer: results of a multicentre study of the GCCLCC (Groupe des Chirurgiens de Centre de Lutte Contre le Cancer) and SFOG (Société Francaise d'Oncologie Gynécologique).
Morice P; Leblanc E; Rey A; Baron M; Querleu D; Blanchot J; Duvillard P; Lhommé C; Castaigne D; Classe JM; Bonnier P;
Hum Reprod; 2005 May; 20(5):1379-85. PubMed ID: 15817592
[TBL] [Abstract][Full Text] [Related]
10. For women receiving chemotherapy for clinically apparent early ovarian cancer, is there a benefit to surgical staging?
Dizon DS; Restivo A; Lomme M; Charbonneau N; Brard L; Hughes T; Weitzen S; Legare R; Granai CO; Disilvestro P
Am J Clin Oncol; 2008 Feb; 31(1):39-42. PubMed ID: 18376226
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy.
Sugiyama T; Kamura T; Kigawa J; Terakawa N; Kikuchi Y; Kita T; Suzuki M; Sato I; Taguchi K
Cancer; 2000 Jun; 88(11):2584-9. PubMed ID: 10861437
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of fertility-sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection.
Satoh T; Hatae M; Watanabe Y; Yaegashi N; Ishiko O; Kodama S; Yamaguchi S; Ochiai K; Takano M; Yokota H; Kawakami Y; Nishimura S; Ogishima D; Nakagawa S; Kobayashi H; Shiozawa T; Nakanishi T; Kamura T; Konishi I; Yoshikawa H
J Clin Oncol; 2010 Apr; 28(10):1727-32. PubMed ID: 20194858
[TBL] [Abstract][Full Text] [Related]
13. Recurrence-predicting prognostic factors for patients with early-stage epithelial ovarian cancer undergoing fertility-sparing surgery: a multi-institutional study.
Kajiyama H; Mizuno M; Shibata K; Yamamoto E; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():97-102. PubMed ID: 24507757
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of clear cell carcinoma of the ovary.
Behbakht K; Randall TC; Benjamin I; Morgan MA; King S; Rubin SC
Gynecol Oncol; 1998 Aug; 70(2):255-8. PubMed ID: 9740700
[TBL] [Abstract][Full Text] [Related]
15. Fertility-sparing surgery in patients with clear-cell carcinoma of the ovary: is it possible?
Kajiyama H; Shibata K; Mizuno M; Hosono S; Kawai M; Nagasaka T; Kikkawa F
Hum Reprod; 2011 Dec; 26(12):3297-302. PubMed ID: 22016417
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy outcomes and menstrual function after fertility sparing surgery for pure ovarian dysgerminomas.
Boran N; Tulunay G; Caliskan E; Köse MF; Haberal A
Arch Gynecol Obstet; 2005 Feb; 271(2):104-8. PubMed ID: 15007601
[TBL] [Abstract][Full Text] [Related]
17. Laparoscopic fertility-sparing staging in unexpected early stage ovarian malignancies.
Muzii L; Palaia I; Sansone M; Calcagno M; Plotti F; Angioli R; Panici PB
Fertil Steril; 2009 Jun; 91(6):2632-7. PubMed ID: 18555237
[TBL] [Abstract][Full Text] [Related]
18. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
[TBL] [Abstract][Full Text] [Related]
19. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
[TBL] [Abstract][Full Text] [Related]
20. Malignant ovarian germ cell tumors: a single-institution experience.
Cicin I; Eralp Y; Saip P; Ayan I; Kebudi R; Iyibozkurt C; Tuzlali S; Gorgun O; Topuz E
Am J Clin Oncol; 2009 Apr; 32(2):191-6. PubMed ID: 19307952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
